A surface-displayed cholera toxin B peptide improves antibody responses using food-grade staphylococci for mucosal subunit vaccine delivery

被引:0
|
作者
Cano, F
Liljeqvist, S
Nguyen, TN
Samuelson, P
Bonnefoy, JY
Ståhl, S [1 ]
Robert, A
机构
[1] Kungliga Tekniska Hogskolan, Dept Biotechnol, S-10044 Stockholm, Sweden
[2] Ctr Immunol Pierre Fabre, F-74164 St Julien En Genevois, France
来源
关键词
surface display; Streptococcus carnosus; cholera toxin B subunit; streptococcal protein G; vaccine delivery;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The possibility of improving the antibody responses to a model streptococcal antigen: administered by intranasal immunization as surface-displayed on the food-grade bacterium Staphylococcus carnosus, by co-exposure of a peptide (CTBp) comprising amino acids 50-75 of the cholera toxin B subunit, was investigated. It was found that the introduction of the CTBp into the chimeric surface proteins, containing a serum albumin binding protein (ABP) from streptococcal protein G as model antigen, significantly increased serum IgG responses upon intranasal immunization. Similarly, elicited local IgA responses were also found to be improved. Furthermore, it was demonstrated that live delivery of the staphylococci was required to obtain this effect, since UV-irradiated or heat-killed bacteria exposing the same chimeric surface proteins did not show increased anti-ABP IgG responses. (C) 1999 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:289 / 298
页数:10
相关论文
共 19 条
  • [1] Cholera toxin B subunit as an immunomodulator for mucosal vaccine delivery
    Russell, MW
    Wu, HY
    Hajishengallis, G
    Hollingshead, SK
    Michalek, SM
    ADVANCES IN VETERINARY MEDICINE, VOL 41: VETERINARY VACCINES AND DIAGNOSTICS, 1999, 41 : 105 - 114
  • [2] Intraperitoneal delivery of cholera toxin B subunit enhances systemic and mucosal antibody responses
    Park, SJ
    Chun, SK
    Kim, PH
    MOLECULES AND CELLS, 2003, 16 (01) : 106 - 112
  • [3] ENHANCEMENT OF PROTECTIVE ANTIBODY-RESPONSES BY CHOLERA TOXIN-B SUBUNIT INOCULATED INTRANASALLY WITH INFLUENZA VACCINE
    TAMURA, S
    SAMEGAI, Y
    KURATA, H
    KIKUTA, K
    NAGAMINE, T
    AIZAWA, C
    KURATA, T
    VACCINE, 1989, 7 (03) : 257 - 262
  • [4] Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant
    Isaka, M
    Yasuda, Y
    Taniguchi, T
    Kozuka, S
    Matano, K
    Maeyama, J
    Morokuma, K
    Ohkuma, K
    Goto, N
    Tochikubo, K
    VACCINE, 2003, 21 (11-12) : 1165 - 1173
  • [5] Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant
    Wu, HY
    Russell, MW
    VACCINE, 1998, 16 (2-3) : 286 - 292
  • [6] An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites
    Nan Sun
    Rongguang Zhang
    Guangcai Duan
    Xiaoyan Peng
    Chen Wang
    Qingtang Fan
    Shuaiyin Chen
    Yuanlin Xi
    BMC Biotechnology, 17
  • [7] An engineered food-grade Lactococcus lactis strain for production and delivery of heat-labile enterotoxin B subunit to mucosal sites
    Sun, Nan
    Zhang, Rongguang
    Duan, Guangcai
    Peng, Xiaoyan
    Wang, Chen
    Fan, Qingtang
    Chen, Shuaiyin
    Xi, Yuanlin
    BMC BIOTECHNOLOGY, 2017, 17
  • [8] Evaluation of Oral Immunization with Recombinant Avian Influenza Virus HA1 Displayed on the Lactococcus lactis Surface and Combined with the Mucosal Adjuvant Cholera Toxin Subunit B
    Lei, Han
    Sheng, Zhina
    Ding, Qian
    Chen, Jian
    Wei, Xiaohui
    Lam, Dominic Man-Kit
    Xu, Yuhong
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (07) : 1046 - 1051
  • [9] M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes
    Shukla, Anshuman
    Katare, O. P.
    Singh, Bhupinder
    Vyas, Suresh P.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 385 (1-2) : 47 - 52
  • [10] Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems
    Harakuni, T
    Sugawa, H
    Komesu, A
    Tadano, M
    Arakawa, T
    INFECTION AND IMMUNITY, 2005, 73 (09) : 5654 - 5665